2014
DOI: 10.1016/j.cbi.2014.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol mitigate structural changes and hepatic stellate cell activation in N′-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
52
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(59 citation statements)
references
References 59 publications
5
52
0
Order By: Relevance
“…Carbon tetrachloride (CCl 4 )-intoxication is a common animal model for studying the mechanism of liver injury as well as hepatoprotective activity of natural and synthetic compounds [3]. There is increasing evidence to suggest that the antioxidant properties of food phenolics is beneficial to liver health, including protection against chemically-induced hepatotoxicity [4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Carbon tetrachloride (CCl 4 )-intoxication is a common animal model for studying the mechanism of liver injury as well as hepatoprotective activity of natural and synthetic compounds [3]. There is increasing evidence to suggest that the antioxidant properties of food phenolics is beneficial to liver health, including protection against chemically-induced hepatotoxicity [4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Several studies have shown RSVmediated mitigating effects on markers of hepatic fibrosis (Chan et al 2011;Chávez et al 2008;Di Pascoli et al 2013;Lee et al 2010) and HSC activation ( Fig. 1Z; Ahmad and Ahmad 2014;Di Pascoli et al 2013;Godichaud et al 2000;Souza et al 2008).…”
Section: Resveratrol Inhibits Ethanol-induced Liver Oxidative Stress mentioning
confidence: 98%
“…The inhibition of fibrotic transdifferentiation of HSC by RES was also established in an in vivo rat model in which hepatic fibrosis was induced by N'-nitrosodimethylamine (NDMA) (22). In this model system, the supplementation with RES subsequent to NDMA administration restored liver architecture, prevented oxidative damage, and blocked expression of fibrotic marker genes in HSC (22).…”
Section: Inhibition Of Hepatic Stellate Cell Activationmentioning
confidence: 99%